Long-term Elevation of Complement Factors in Cerebrospinal Fluid of Patients With Borna Disease Virus 1 Encephalitis

• Published in: The Journal of infectious diseases Vol. 230; no. 4; pp. e943 - e953
• Main Authors: Bauswein, Markus, Zoubaa, Saida, Toelge, Martina, Eidenschink, Lisa, Riemenschneider, Markus J, Neumann, Bernhard, Lee, De-Hyung, Eid, Ehab, Tappe, Dennis, Niller, Hans Helmut, Gessner, André, Schmidt, Barbara, Bülow, Sigrid, Angstwurm, Klemens
• Format: Journal Article
• Language: English
• Published: United States Oxford University Press 16-10-2024
• Subjects: Adolescent; Adult; Aged; Borna Disease - cerebrospinal fluid; Borna Disease - immunology; Borna Disease - virology; Borna disease virus - immunology; Brain - immunology; Brain - pathology; Brain - virology; Child; Child, Preschool; Complement System Proteins - cerebrospinal fluid; Complement System Proteins - immunology; Complement System Proteins - metabolism; Female; Humans; Infant; Major; Male; Middle Aged; Young Adult; immunopathogenesis; zoonosis; biomarkers; complement system; BoDV-1
• ISSN: 0022-1899; 1537-6613; 1537-6613
• DOI: 10.1093/infdis/jiae183

Borna disease virus 1 (BoDV-1) causes rare but severe zoonotic infections in humans, presenting as encephalitis. The case-fatality risk is very high and no effective countermeasures have been established so far. An immunopathology is presumed, while data on immune responses in humans are limited. Evidence of a role of the complement system in various neurological disorders and in viral infections of the central nervous system is increasing and specific inhibitors are available as therapeutic options.
In this study, we investigated factors of the complement system in the cerebrospinal fluid (CSF) of patients with BoDV-1 infections (n = 17) in comparison to noninflammatory control CSF samples (n = 11), using a bead-based multiplex assay. In addition, immunohistochemistry was performed using postmortem brain tissue samples.
We found an intrathecal elevation of complement factors of all complement pathways and an active cascade during human BoDV-1 infections. The increase of certain complement factors such as C1q was persistent, and C3 complement deposits were detected in postmortem brain sections. Intrathecal complement levels were negatively correlated with survival.
Further investigations are warranted to clarify whether targeting the complement cascade by specific inhibitors might be beneficial for patients suffering from severe BoDV-1 encephalitis.